Rockwell Medical (RMTI) Net Cash Flow (2010 - 2026)

Rockwell Medical (RMTI) has reported Net Cash Flow for 17 consecutive years, with $943000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 13.57% year-over-year to $943000.0; the trailing twelve-month figure through Jun 2026 stood at -$2.0 million (down 422.71% YoY), and the FY2025 full-year result was -$5.0 million, down 174.69% from the prior year.
• Net Cash Flow grew to $943000.0 in Q2 2026 per RMTI's latest filing, from -$1.1 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $20.9 million in Q2 2022 and bottomed at -$17.8 million in Q3 2022.
• Historically, Net Cash Flow has averaged -$155000.0 across 5 years, with a median of -$329500.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow soared 732.94% in 2022, then slumped 394.47% in 2024.
• Over 5 years, Net Cash Flow stood at -$2.9 million in 2022, then surged by 142.49% to $1.2 million in 2023, then jumped by 171.87% to $3.3 million in 2024, then plunged by 186.92% to -$2.9 million in 2025, then surged by 132.63% to $943000.0 in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $943000.0, -$1.1 million, and -$2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.